Stolper Co Raises Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

Stolper Co grew its holdings in UnitedHealth Group Incorporated (NYSE:UNHGet Rating) by 0.5% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 16,890 shares of the healthcare conglomerate’s stock after purchasing an additional 85 shares during the quarter. UnitedHealth Group makes up approximately 3.9% of Stolper Co’s holdings, making the stock its 3rd biggest holding. Stolper Co’s holdings in UnitedHealth Group were worth $8,955,000 at the end of the most recent quarter.

Other hedge funds also recently modified their holdings of the company. Vanguard Group Inc. boosted its stake in UnitedHealth Group by 1.0% during the 3rd quarter. Vanguard Group Inc. now owns 82,969,869 shares of the healthcare conglomerate’s stock worth $41,903,103,000 after acquiring an additional 851,994 shares during the last quarter. FMR LLC raised its holdings in UnitedHealth Group by 2.0% during the 2nd quarter. FMR LLC now owns 49,813,470 shares of the healthcare conglomerate’s stock worth $25,585,693,000 after buying an additional 998,214 shares during the period. Price T Rowe Associates Inc. MD raised its holdings in shares of UnitedHealth Group by 17.8% in the second quarter. Price T Rowe Associates Inc. MD now owns 36,853,394 shares of the healthcare conglomerate’s stock valued at $18,929,009,000 after purchasing an additional 5,556,335 shares during the last quarter. Nuveen Asset Management LLC raised its holdings in shares of UnitedHealth Group by 5.3% in the third quarter. Nuveen Asset Management LLC now owns 7,276,059 shares of the healthcare conglomerate’s stock valued at $3,674,701,000 after purchasing an additional 367,153 shares during the last quarter. Finally, Legal & General Group Plc increased its holdings in UnitedHealth Group by 2.1% during the second quarter. Legal & General Group Plc now owns 6,963,772 shares of the healthcare conglomerate’s stock worth $3,576,829,000 after buying an additional 143,238 shares during the last quarter. Institutional investors own 86.31% of the company’s stock.

UnitedHealth Group Stock Down 0.5 %

UNH stock opened at $469.50 on Friday. The company has a market cap of $437.97 billion, a PE ratio of 22.16, a price-to-earnings-growth ratio of 1.32 and a beta of 0.69. The business has a 50-day simple moving average of $483.26 and a 200 day simple moving average of $510.69. UnitedHealth Group Incorporated has a 52 week low of $449.70 and a 52 week high of $558.10. The company has a quick ratio of 0.77, a current ratio of 0.77 and a debt-to-equity ratio of 0.67.

UnitedHealth Group (NYSE:UNHGet Rating) last posted its quarterly earnings results on Friday, January 13th. The healthcare conglomerate reported $5.34 EPS for the quarter, beating analysts’ consensus estimates of $5.17 by $0.17. The business had revenue of $82.79 billion during the quarter, compared to the consensus estimate of $82.53 billion. UnitedHealth Group had a return on equity of 27.04% and a net margin of 6.21%. UnitedHealth Group’s revenue for the quarter was up 12.3% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $4.48 earnings per share. Sell-side analysts anticipate that UnitedHealth Group Incorporated will post 24.91 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, March 21st. Shareholders of record on Monday, March 13th will be paid a dividend of $1.65 per share. This represents a $6.60 annualized dividend and a yield of 1.41%. The ex-dividend date of this dividend is Friday, March 10th. UnitedHealth Group’s payout ratio is 31.15%.

Analyst Ratings Changes

A number of equities analysts recently weighed in on the stock. Loop Capital boosted their target price on shares of UnitedHealth Group from $575.00 to $590.00 in a report on Tuesday, January 17th. Credit Suisse Group lifted their price objective on shares of UnitedHealth Group from $590.00 to $610.00 and gave the stock an “outperform” rating in a research report on Wednesday, December 7th. Morgan Stanley reaffirmed an “overweight” rating and set a $587.00 price objective on shares of UnitedHealth Group in a research report on Wednesday, November 23rd. Raymond James cut shares of UnitedHealth Group from a “strong-buy” rating to an “outperform” rating and set a $615.00 price objective for the company. in a research report on Monday, November 21st. Finally, Deutsche Bank Aktiengesellschaft lifted their price objective on shares of UnitedHealth Group from $615.00 to $617.00 and gave the stock a “buy” rating in a research report on Tuesday, January 24th. Three investment analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $599.68.

UnitedHealth Group Company Profile

(Get Rating)

UnitedHealth Group, Inc engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum’s capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience.

Featured Stories

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.